A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.

Wong SF, Unger JM, Wade JL 3rd, Wagner LI, Lacouture ME, Humphries KC, Moseley A, Arnold K, Velasco MR Jr, Floyd JD, Esparaz BT, Barzi A, Lenz HJ, Koczywas M, Dakhil S, Burton GV, Fisch MJ, Henry NL, Hershman DL, Moinpour CM

Open source

DOI: 10.1186/s41687-020-00220-x
Published: 2020 Jul 8
Container: Journal of patient-reported outcomes
Publisher: figshare
Open access: yes

Credibility signals

uncertain Score 61/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s41687-020-00220-x,
  title = {A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.},
  author = {Wong SF and Unger JM and Wade JL 3rd and Wagner LI and Lacouture ME and Humphries KC and Moseley A and Arnold K and Velasco MR Jr and Floyd JD and Esparaz BT and Barzi A and Lenz HJ and Koczywas M and Dakhil S and Burton GV and Fisch MJ and Henry NL and Hershman DL and Moinpour CM},
  year = {2020},
  journal = {Journal of patient-reported outcomes},
  doi = {10.1186/s41687-020-00220-x},
  url = {https://doi.org/10.1186/s41687-020-00220-x}
}

RIS

TY  - JOUR
TI  - A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.
AU  - Wong SF
AU  - Unger JM
AU  - Wade JL 3rd
AU  - Wagner LI
AU  - Lacouture ME
AU  - Humphries KC
AU  - Moseley A
AU  - Arnold K
AU  - Velasco MR Jr
AU  - Floyd JD
AU  - Esparaz BT
AU  - Barzi A
AU  - Lenz HJ
AU  - Koczywas M
AU  - Dakhil S
AU  - Burton GV
AU  - Fisch MJ
AU  - Henry NL
AU  - Hershman DL
AU  - Moinpour CM
PY  - 2020
JO  - Journal of patient-reported outcomes
DO  - 10.1186/s41687-020-00220-x
UR  - https://doi.org/10.1186/s41687-020-00220-x
ER  -

APA

SF, W., JM, U., 3rd, W. J., LI, W., ME, L., KC, H., A, M., K, A., Jr, V. M., JD, F., BT, E., A, B., HJ, L., M, K., S, D., GV, B., MJ, F., NL, H., DL, H., & CM, M. (2020). A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.. Journal of patient-reported outcomes. https://doi.org/10.1186/s41687-020-00220-x

Source records

pubmed · retrieved 2026-09-26T01:29:56.592Z
europe-pmc · retrieved 2026-09-26T01:29:56.604Z
datacite · retrieved 2026-09-26T01:29:56.579Z
datacite · retrieved 2026-09-26T01:29:56.579Z
doaj · retrieved 2026-09-26T01:29:56.620Z